close
References
  1. Bose G, Freedman MS. Precision medicine in the multiple sclerosis clinic: selecting the right patient for the right treatment. Mult Scler. 2020;26(5):540-547.
  2. Comi G, Radaelli M, Sørensen PS. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet. 2017;389(10076):1347-1356.
  3. De Stefano N, Stromillo ML, Giorgio A, et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016;87(1):93-99.
  4. Fox RJ, Rae-Grant AD, Bethoux F. Multiple Sclerosis and Related Disorders. 2nd ed. Demos Medical; 2018.
  5. Fox RJ, Cohen A. Multiple sclerosis: the importance of early recognition and treatment. Cleve Clin J Med. 2001;68(2):157-171.
  6. Giovannoni G, Butzkueven H, Dhib-Jalbut S, et al. Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord. 2016;9 Suppl:S5-S48.
  7. Hansen MR, Okuda DT. Multiple sclerosis in the contemporary age: understanding the millennial patient with multiple sclerosis to create next-generation care. Neurol Clin. 2018;36(1):219-230.
  8. Krieger SC, Cook K, De Nino S, Fletcher M. The topographical model of multiple sclerosis: a dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e279.
  9. MS International Federation. Statistics. www.atlasofms.org/map/united-states-of-america/epidemiology/number-of-people-with-ms. Accessed December 20, 2020.
  10. MS International Federation. Who gets MS? www.nationalmssociety.org/What-is-MS/Who-Gets-MS. Accessed December 20, 2020.
  11. National Multiple Sclerosis Society. How many people live with MS? www.nationalmssociety.org/What-is-MS/How-Many-People. Accessed December 20, 2020.
  12. Rotstein DL, Healy BC, Malik MT, Chitnis T, Weiner HL. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. JAMA Neurol. 2015;72(2):152-158.
  13. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
  14. Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis - success from bench to bedside. Nat Rev Neurol. 2019;15(1):53-58.
  15. Wallin MT, Culpepper WJ, Campbell JD, et al; US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029-e1040.
  16. Wattjes MP, Steenwijk MD, Stangel M. MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clin Neuroradiol. 2015;25 Suppl 2:157-165.